NL-OMON39373已完成4 期
A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after Transplantation - Spartacus
niversitair Medisch Centrum Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
Trial is onging in other countries
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients * 18 years;* Patients admitted to the ICC of UMCU after heart or lung transplantation;* Treated with tacrolimus (Prograft®; Astellas Pharma Europe);* Informed consent obtained
排除标准
- •* Patients < 18 years;* Patients who die within one day after admission to the ICC of UMCU;* Withdrawal of informed consent;* Allergy towards tacrolimus or macrolides;* Patients on total parenteral nutrition
研究者
相似试验
已完成
不适用
A Prospective, Multicenter, Open Label, Single Arm, Study to Assess the Safety & Performance of the Harmony Aortic Stimulation System (HASS) for the Treatment of Heart FailureCardiac Failure10019280Heart FailureNL-OMON51726van de Wetering CRC2
已完成
2 期
A randomized, open-label, parallel-group, multi-center study of adding edoxaban or clopidogrel to aspirin to maintain patency in subjects with peripheral arterial disease following femoropopliteal endovascular intervention-edoxaban in peripheral arterial disease (ePAD)narrowing of the peripheral arteries (mostly in the legs)periferal arterial disease10003216NL-OMON40071Daiichi Sankyo Development Ltd14
已完成
3 期
A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation In Patients with Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation.split personalitySchizofrenia10037173NL-OMON43400Janssen-Cilag6
已完成
4 期
A Prospective, Randomized, Multi-center Study to Assess the SaFety of the Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for Bleeding in combination With 1-month Dual Antiplatelet Therapy (DAPT).NL-OMON52323BIOTRONIK AG1
已完成
2 期
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) [DELIVERS Study]NL-OMON47706Castle Creek Pharmaceuticals, LLC4